Suchergebnisse - "Neuroblastoma"

PubPharm (11.554)

1

Identification of immune-related signature with prognosis in children with stage 4 and 4S neuroblastoma

enthalten in: Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico | 2024

von Cao, L. | Liu, Q. | Ma, Y. | +1

2

Evolution and contemporary role of metronomic chemotherapy in the treatment of neuroblastoma

enthalten in: Cancer letters | 2024

von Chou, S. | Chang, H.

3

Prediction of High-Risk Neuroblastoma Among Neuroblastic Tumors Using Radiomics Features Derived from Magnetic Resonance Imaging : A Pilot Study

enthalten in: Yonsei medical journal | 2024

von Kim, J. | Choi, Y. | Yoon, H. | +3

4

Cell communication pathway prognostic model identified detrimental neurodevelopmental pathways in neuroblastoma

enthalten in: Neoplasia (New York, N.Y.) | 2024

von Wang, J. | Li, H. | Xue, Y. | +7

5

A nationwide phase II study of delayed local treatment for children with high-risk neuroblastoma : The Japan Children's Cancer Group Neuroblastoma Committee Trial JN-H-11

enthalten in: Pediatric blood & cancer | 2024

von Yoneda, A. | Shichino, H. | Hishiki, T. | +17

6

Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies : Comprehensive Omics Analysis of Pediatric Solid Tumors and Establishment of a Repository for Related Biological Studies

enthalten in: ClinicalTrials.gov | 2024

7

NK White Blood Cells and Interleukin in Children and Young Adults With Advanced Solid Tumors : A Phase I Study of Autologous Activated Natural Killer (NK) Cells +/- rhIL15 in Children and Young Adults With Refractory Solid Tumors

enthalten in: ClinicalTrials.gov | 2024

8

Engineered Neuroblastoma Cellular Immunotherapy (ENCIT)-01 : A Phase 1 Feasibility and Safety Study of Cellular Immunotherapy for Recurrent/Refractory Neuroblastoma Using Autologous T-cells Lentivirally Transduced to Express CD171-specific Chimeric Antigen Receptors

enthalten in: ClinicalTrials.gov | 2024

9

Study of CAR T-Cells Targeting the GD2 With IL-15+iCaspase9 for Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma : A Phase I Study of Autologous Activated T-Cells Expressing a 2nd Generation GD2 Chimeric Antigen Receptor, IL-15, and iCaspase9 Safety Switch Administered To Patients With Relapsed/Refractory Neuroblastoma or Relapsed/Refractory Osteosarcoma

enthalten in: ClinicalTrials.gov | 2024

10

B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults : Phase I Study of B7H3 CAR T Cell Immunotherapy for Recurrent/Refractory Solid Tumors in Children and Young Adults

enthalten in: ClinicalTrials.gov | 2024

1
2
3
4
5
6
7
8
9
10
11
Nächster »
[1156]